Recursion raises $200M as Sanofi milestone lands
Alpha Vantage · Seeking Alpha · · AI-summarised by FinFlash
Recursion announced a $200 million equity offering, sending its shares down more than 4% in premarket trading. The raise overshadowed news that Sanofi selected its first development candidate under a collaboration with Recursion. The mixed reaction shows dilution concerns outweighing pipeline validation for now, leaving investors focused on how the new capital is deployed.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.